Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Gains from Investment Securities (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Gains from Investment Securities readings, the most recent being $599000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 267.32% to $599000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$151000.0, a 99.04% increase, with the full-year FY2025 number at $7.2 million, down 7.62% from a year prior.
  • Gains from Investment Securities hit $599000.0 in Q4 2025 for Treace Medical Concepts, down from $852220.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.8 million in Q3 2021 to a low of -$15.2 million in Q4 2022.
  • Median Gains from Investment Securities over the past 5 years was $771785.0 (2023), compared with a mean of -$97359.4.
  • Biggest five-year swings in Gains from Investment Securities: soared 7758.91% in 2021 and later tumbled 113.11% in 2025.
  • Treace Medical Concepts' Gains from Investment Securities stood at $1.8 million in 2021, then tumbled by 947.65% to -$15.2 million in 2022, then skyrocketed by 98.65% to -$205000.0 in 2023, then plummeted by 74.63% to -$358000.0 in 2024, then surged by 267.32% to $599000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $599000.0 (Q4 2025), $852220.0 (Q3 2025), and $852220.0 (Q2 2025) per Business Quant data.